Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_2
3
75%
Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (75.0%)
N/A1 (25.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Effective Maneuver for Post-laparoscopic Shoulder Pain

NCT02811081
completedphase_2

Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding

NCT01733290
completedphase_2

Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment

NCT01969773
completedphase_2

Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome

NCT01167257

Clinical Trials (4)

Showing 4 of 4 trials
NCT02811081Not Applicable

Effective Maneuver for Post-laparoscopic Shoulder Pain

Completed
NCT01733290Phase 2

Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding

Completed
NCT01969773Phase 2

Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment

Completed
NCT01167257Phase 2

Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4